May 1, 2025 - 19:10

TeraWatt Technology Inc. has proudly announced the achievement of ISO 9001 certification for its lithium-ion battery manufacturing facility located in Shizuoka Prefecture, Japan. This significant milestone underscores the company's commitment to maintaining high-quality standards in its production processes.
The Shizuoka facility marks TeraWatt's first mass production site, and the certification is a testament to the rigorous quality management systems implemented throughout its operations. ISO 9001 is a globally recognized standard that ensures organizations consistently meet customer and regulatory requirements while enhancing customer satisfaction.
The certification process involved thorough assessments and audits, confirming that TeraWatt's facility adheres to international quality management principles. This achievement positions TeraWatt as a reliable player in the lithium-ion battery market, catering to the growing demand for high-performance energy storage solutions.
As the company continues to expand its production capabilities, this certification will play a crucial role in fostering trust among clients and stakeholders in the evolving energy landscape.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...